We are live on ! Find out more
OPK icon

Opko Health

218 hedge funds and large institutions have $259M invested in Opko Health in 2023 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 53 increasing their positions, 65 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

655% more call options, than puts

Call options by funds: $5.35M | Put options by funds: $708K

0.59% more ownership

Funds ownership: 21.63%22.22% (+0.59%)

3% less capital invested

Capital invested by funds: $268M → $259M (-$8.2M)

3% less funds holding

Funds holding: 225218 (-7)

18% less repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 65

22% less first-time investments, than exits

New positions opened: 25 | Existing positions closed: 32

Holders
218
Holders Change
-7
Holders Change %
-3.11%
% of All Funds
3.18%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
25
Increased
53
Reduced
65
Closed
32
Calls
$5.35M
Puts
$708K
Net Calls
+$4.64M
Net Calls Change
+$2.74M
Name Holding Trade Value Shares
Change
Change in
Stake
Group One Trading
51
Group One Trading
Illinois
$466K +$446K +308,615 New
First Trust Advisors
52
First Trust Advisors
Illinois
$462K +$442K +305,731 New
Royal Bank of Canada
53
Royal Bank of Canada
Ontario, Canada
$460K +$72.6K +50,248 +20%
American Century Companies
54
American Century Companies
Missouri
$418K -$1.46K -1,008 -0.4%
BNP Paribas Financial Markets
55
BNP Paribas Financial Markets
France
$411K +$306K +211,429 +350%
ECM
56
ExodusPoint Capital Management
New York
$401K +$367K +253,741 +2,099%
Tudor Investment Corp
57
Tudor Investment Corp
Connecticut
$370K
SG Americas Securities
58
SG Americas Securities
New York
$369K +$57K +39,459 +19%
GCM
59
Graham Capital Management
Connecticut
$356K +$68.7K +47,543 +25%
Manulife (Manufacturers Life Insurance)
60
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$355K -$9.15K -6,330 -3%
MIM
61
MetLife Investment Management
New Jersey
$319K
Janus Henderson Group
62
Janus Henderson Group
United Kingdom
$314K -$499 -345 -0.2%
AIG
63
American International Group
New York
$303K -$1.17K -810 -0.4%
Franklin Resources
64
Franklin Resources
California
$293K
Wells Fargo
65
Wells Fargo
California
$281K +$21.2K +14,682 +9%
GI
66
GAMCO Investors
Connecticut
$279K -$21.7K -15,000 -8%
GF
67
Gabelli Funds
New York
$273K
XSC
68
X-Square Capital
Puerto Rico
$269K -$3.14K -2,170 -1%
State Board of Administration of Florida Retirement System
69
State Board of Administration of Florida Retirement System
Florida
$266K
TA
70
Teton Advisors
New York
$257K -$11.6K -8,000 -4%
PIS
71
POM Investment Strategies
North Carolina
$239K +$228K +158,053 New
Simplex Trading
72
Simplex Trading
Illinois
$224K +$214K +148,360 New
Parallax Volatility Advisers
73
Parallax Volatility Advisers
California
$203K +$194K +134,280 New
VanEck Associates
74
VanEck Associates
New York
$201K -$25.8K -17,836 -12%
WSTAM
75
Wilbanks Smith & Thomas Asset Management
Virginia
$198K

OPK Hedge Fund Activity: Q4 2023 in Review

218 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Opko Health (OPK) for Q4 2023, worth a combined $259M — down 3.1% from $268M a quarter earlier.

Sellers outnumbered buyers: 32 funds closed out of OPK and 25 opened new positions — a net loss of 7 holders — while 65 trimmed existing stakes and 53 added.

The largest buyer was Morgan Stanley, adding an estimated $3.33M. The largest seller was Nuveen, cutting an estimated $2.19M.

  • 218 institutional investors held Opko Health (OPK) as of Q4 2023, down from 225 in Q3 2023.
  • Funds reported $259M of Opko Health stock for Q4 2023, down 3.1% quarter-over-quarter.
  • 25 funds opened new Opko Health positions in Q4 2023 and 32 closed out, a net change of -7 holders.
  • The largest Opko Health buyer in Q4 2023 was Morgan Stanley, an estimated $3.33M added.
  • The largest Opko Health seller in Q4 2023 was Nuveen, an estimated $2.19M sold.

Based on aggregated 13F filings for Q4 2023.